Ribometrix, Inc.
Pharmaceutical company · Greenville, North Carolina, United States
Ribometrix, Inc. is a pharmaceutical company headquartered in Greenville, North Carolina, United States. Its earliest recorded incorporation is in 2014. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $673,811 in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2018.
Ribometrix at a glance
What does Ribometrix do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $673,811 in total (2016 to 2017). NIH funding came from the National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $15 million sold (2018).
Frequently asked questions about Ribometrix
Where is Ribometrix headquartered?
Ribometrix, Inc. is headquartered in Greenville, North Carolina, United States.
What does Ribometrix do?
Ribometrix, Inc. is a pharmaceutical company.
When was Ribometrix founded?
The earliest incorporation on record for Ribometrix, Inc. is in 2014, according to public company registers.
Similar companies
- Zylo Therapeutics Inc.Greenville, South Carolina, United States
- Fervent Pharmaceuticals LLCGreenville, North Carolina, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences